Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Farmax India's Enterprise Value is $8.73 Mil.
Farmax India's EBIT for the trailing twelve months (TTM) ended in Dec. 2017 was $-0.09 Mil. Therefore, Farmax India's EV-to-EBIT ratio for today is -101.51.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Farmax India's Enterprise Value is $8.73 Mil.
Farmax India's EBITDA for the trailing twelve months (TTM) ended in Dec. 2017 was $0.01 Mil. Therefore, Farmax India's EV-to-EBITDA ratio for today is 623.57.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Farmax India's Enterprise Value is $8.73 Mil.
Farmax India's Revenue for the trailing twelve months (TTM) ended in Dec. 2017 was $0.02 Mil. Therefore, Farmax India's EV-to-Revenue ratio for today is 582.00.
Farmax India Enterprise Value Historical Data
The historical data trend for Farmax India's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Farmax India's Enterprise Value
For the Packaged Foods subindustry, Farmax India's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Farmax India's Enterprise Value Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Farmax India's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Farmax India's Enterprise Value falls into.
Farmax India Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Farmax India's Enterprise Value for the fiscal year that ended in Mar. 2017 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Farmax India (LUX:FARMX) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Farmax India's current Enterprise Value is $8.73 Mil.
Farmax India's EBIT for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.09 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Farmax India's current Enterprise Value is $8.73 Mil.
Farmax India's EBITDA for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.
Farmax India's current Enterprise Value is $8.73 Mil.
Farmax India's Revenue for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Farmax India Enterprise Value Related Terms
Thank you for viewing the detailed overview of Farmax India's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Farmax India Ltd is mainly engaged in the manufacturing and marketing of fast moving consumer goods. The company offers food products; personal care products, soaps and detergent powders under the brand name Today, D' Lite, Deevena, Farmax, Monsoon, and Cas brands.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LUX:FARMX has been successfully added to your 